- Record: found
- Abstract: not found
- Book: not found
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer: Food and Drug Administration
2020
Read this book at
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.